Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$712K Buy
4,899
+340
+7% +$42.2K ﹤0.01% 932
2026
Q1
$484K Buy
4,559
+716
+19% +$81.4K ﹤0.01% 1032
2025
Q4
$409K Buy
3,843
+29
+0.8% +$2.93K ﹤0.01% 1026
2025
Q3
$357K Buy
3,814
+37
+1% +$3.44K ﹤0.01% 1083
2025
Q2
$328K Buy
3,777
+123
+3% +$10.3K ﹤0.01% 1102
2025
Q1
$282K Buy
3,654
+149
+4% +$13.7K ﹤0.01% 1125
2024
Q4
$339K Buy
3,505
+319
+10% +$32.1K ﹤0.01% 1090
2024
Q3
$302K Buy
3,186
+113
+4% +$9.87K ﹤0.01% 1087
2024
Q2
$256K Buy
3,073
+130
+4% +$10.8K ﹤0.01% 1097
2024
Q1
$253K Buy
2,943
+17
+0.6% +$1.38K ﹤0.01% 1112
2023
Q4
$242K Buy
2,926
+37
+1% +$2.71K ﹤0.01% 1109
2023
Q3
$208K Buy
2,889
+33
+1% +$2.5K ﹤0.01% 1113
2023
Q2
$216K Buy
+2,856
New +$192K ﹤0.01% 1129

Other funds holding ACA

Xponance's ACA Position: Q2 2026 in Review

Xponance increased its Arcosa (ACA) stake by 7.5% in Q2 2026, buying an estimated $42.2K and bringing the position to 4,899 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

Xponance first reported a position in ACA in Q2 2023 and has held it in 13 quarters since. 425 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • Xponance held 4,899 shares of Arcosa worth $712K as of Q2 2026.
  • Xponance bought 340 Arcosa shares in Q2 2026, an estimated $42.2K.
  • Arcosa made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #932 holding.
  • Xponance first reported a position in Arcosa in Q2 2023 and has held it in 13 quarters since.
  • 425 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.